MapLight Therapeutics Insider Trades
NASDAQ: MPLTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 6 · $65.54M
- Sales
- 81 · $21.42M
- Shares bought / sold
- 5.62M / 783.38K
- Net activity
- Net buying $44.1 million
MapLight Therapeutics insider activity
Over the last 12 months, MapLight Therapeutics insiders reported 100 transactions on SEC Form 4: 6 open-market purchases and 81 sales. Insiders bought $65.5 million and sold $21.4 million worth of stock, for net insider buying of $44.1 million. The largest seller was Kroeger Christopher A., with $11.9 million in reported sales.
The most recent filing shows GILLIS JONATHAN (CAO and Interim CFO) selling 10,167 shares at $8.08 on Oct 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MPLT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
MPLT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 15, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 73,691 | $595.42K | Form 4 |
| Oct 15, 2026 | Foff Erin PennockChief Medical Officer | Sale | 15,355 | $124.07K | Form 4 |
| Oct 15, 2026 | Hanson KristopherGeneral Counsel | Sale | 9,020 | $72.88K | Form 4 |
| Oct 15, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 12,248 | $96.02K | Form 4 |
| Oct 15, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 11,513 | $93.03K | Form 4 |
| Oct 15, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 10,167 | $82.15K | Form 4 |
| Sep 16, 2026 | Hanson KristopherGeneral Counsel | Sale | 16,509 | $192.66K | Form 4 |
| Aug 17, 2026 | Kroeger Christopher A.Chief Executive Officer | Award | 23,145 | — | Form 4 |
| Aug 17, 2026 | Foff Erin PennockChief Medical Officer | Award | 13,360 | — | Form 4 |
| Aug 17, 2026 | Lillie James WoodruffChief Scientific Officer | Award | 7,730 | — | Form 4 |
| Aug 17, 2026 | GILLIS JONATHANCAO and Interim CFO | Award | 2,222 | — | Form 4 |
| Aug 17, 2026 | GILLIS JONATHANCAO and Interim CFO | Award | 6,020 | — | Form 4 |
| Aug 17, 2026 | Hanson KristopherGeneral Counsel | Award | 7,730 | — | Form 4 |
| Aug 17, 2026 | Kreitzer AnatolChief Discovery Officer | Award | 6,020 | — | Form 4 |
| Aug 14, 2026 | Catalyst4, Inc.10% Owner | Buy | 4,400,000 | $50.07M | Form 4 |
| Aug 3, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 22,082 | $276.91K | Form 4 |
| Jul 30, 2026 | Catalyst4, Inc.10% Owner | Buy | 1,000,000 | $13.00M | Form 4 |
| Jul 29, 2026 | Catalyst4, Inc.10% Owner | Buy | 3,000 | $37.89K | Form 4 |
| Jul 28, 2026 | Cox TroyDirector | Buy | 15,620 | $148.70K | Form 4 |
| Jul 28, 2026 | Catalyst4, Inc.10% Owner | Buy | 65,137 | $761.39K | Form 4 |
| Jul 28, 2026 | Catalyst4, Inc.10% Owner | Buy | 141,088 | $1.52M | Form 4 |
| Jul 17, 2026 | Hanson KristopherGeneral Counsel | Sale | 1,130 | $42.83K | Form 4 |
| Jul 17, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 2,077 | $78.72K | Form 4 |
| Jul 17, 2026 | Foff Erin PennockChief Medical Officer | Sale | 3,656 | $138.56K | Form 4 |
| Jul 17, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 16,779 | $635.92K | Form 4 |
| Jul 17, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 200 | $7.68K | Form 4 |
| Jul 17, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 14,140 | $533.08K | Form 4 |
| Jul 17, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 2,833 | $104.96K | Form 4 |
| Jul 17, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 900 | $34.35K | Form 4 |
| Jul 17, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 16,969 | $638.20K | Form 4 |
| Jul 17, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 600 | $21.91K | Form 4 |
| Jul 16, 2026 | Hanson KristopherGeneral Counsel | Sale | 11 | $417.56 | Form 4 |
| Jul 16, 2026 | Hanson KristopherGeneral Counsel | Sale | 3,331 | $124.11K | Form 4 |
| Jul 16, 2026 | Hanson KristopherGeneral Counsel | Sale | 4,776 | $174.09K | Form 4 |
| Jul 16, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 12 | $455.52 | Form 4 |
| Jul 16, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 3,526 | $131.38K | Form 4 |
| Jul 16, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 5,009 | $182.58K | Form 4 |
| Jul 16, 2026 | Foff Erin PennockChief Medical Officer | Sale | 19 | $721.24 | Form 4 |
| Jul 16, 2026 | Foff Erin PennockChief Medical Officer | Sale | 5,865 | $218.53K | Form 4 |
| Jul 16, 2026 | Foff Erin PennockChief Medical Officer | Sale | 9,163 | $334.08K | Form 4 |
| Jul 16, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 92 | $3.49K | Form 4 |
| Jul 16, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 28,091 | $1.05M | Form 4 |
| Jul 16, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 40,899 | $1.49M | Form 4 |
| Jul 16, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 1,592 | $59.60K | Form 4 |
| Jul 16, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 7,464 | $273.63K | Form 4 |
| Jul 16, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 1,476 | $55.26K | Form 4 |
| Jul 16, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 6,979 | $255.85K | Form 4 |
| Jul 15, 2026 | Hanson KristopherGeneral Counsel | Sale | 10 | $375.40 | Form 4 |
| Jul 15, 2026 | Hanson KristopherGeneral Counsel | Sale | 5,103 | $188.76K | Form 4 |
| Jul 15, 2026 | Hanson KristopherGeneral Counsel | Sale | 2,147 | $77.29K | Form 4 |
| Jul 15, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 12 | $450.48 | Form 4 |
| Jul 15, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 5,393 | $199.49K | Form 4 |
| Jul 15, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 2,238 | $80.57K | Form 4 |
| Jul 15, 2026 | Foff Erin PennockChief Medical Officer | Sale | 18 | $675.72 | Form 4 |
| Jul 15, 2026 | Foff Erin PennockChief Medical Officer | Sale | 8,972 | $331.87K | Form 4 |
| Jul 15, 2026 | Foff Erin PennockChief Medical Officer | Sale | 4,465 | $160.74K | Form 4 |
| Jul 15, 2026 | Foff Erin PennockChief Medical Officer | Sale | 7,845 | $290.58K | Form 4 |
| Jul 15, 2026 | Foff Erin PennockChief Medical Officer | Sale | 7,155 | $258.72K | Form 4 |
| Jul 15, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 90 | $3.38K | Form 4 |
| Jul 15, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 42,738 | $1.58M | Form 4 |
| Jul 15, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 18,950 | $682.20K | Form 4 |
| Jul 15, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 4,510 | $166.60K | Form 4 |
| Jul 15, 2026 | Kreitzer AnatolChief Discovery Officer | Sale | 5,545 | $200.34K | Form 4 |
| Jul 15, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 4,699 | $173.58K | Form 4 |
| Jul 15, 2026 | GILLIS JONATHANCAO and Interim CFO | Sale | 5,356 | $193.51K | Form 4 |
| Jun 23, 2026 | Walker Maria CDirector | Award | 3,932 | — | Form 4 |
| Jun 23, 2026 | Pavlov GeorgeDirector | Award | 3,932 | — | Form 4 |
| Jun 23, 2026 | Luneborg Nanna LiebachDirector | Award | 3,932 | — | Form 4 |
| Jun 23, 2026 | Babler MartinDirector | Award | 7,864 | — | Form 4 |
| Jun 23, 2026 | Garnett Timothy JohnDirector | Award | 3,932 | — | Form 4 |
| Jun 23, 2026 | Cox TroyDirector | Award | 7,864 | — | Form 4 |
| May 18, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 198 | $5.57K | Form 4 |
| May 18, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 118,037 | $3.21M | Form 4 |
| May 11, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 5,890 | $180.00K | Form 4 |
| May 11, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 6,871 | $206.40K | Form 4 |
| May 11, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 877 | $25.17K | Form 4 |
| May 11, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 342 | $9.43K | Form 4 |
| May 11, 2026 | Hanson KristopherGeneral Counsel | Sale | 5,808 | $177.49K | Form 4 |
| May 11, 2026 | Hanson KristopherGeneral Counsel | Sale | 6,979 | $209.65K | Form 4 |
| May 11, 2026 | Hanson KristopherGeneral Counsel | Sale | 846 | $24.28K | Form 4 |
| May 11, 2026 | Hanson KristopherGeneral Counsel | Sale | 284 | $7.84K | Form 4 |
| May 8, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 3,205 | $93.59K | Form 4 |
| May 8, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 1,582 | $45.18K | Form 4 |
| May 8, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 29,624 | $814.07K | Form 4 |
| May 7, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 721 | $20.39K | Form 4 |
| May 7, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 5,220 | $152.16K | Form 4 |
| May 7, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 14,880 | $423.63K | Form 4 |
| May 7, 2026 | Foff Erin PennockChief Medical Officer | Sale | 117 | $3.40K | Form 4 |
| May 7, 2026 | Foff Erin PennockChief Medical Officer | Sale | 4,321 | $123.23K | Form 4 |
| May 6, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 15,603 | $454.52K | Form 4 |
| May 6, 2026 | Kroeger Christopher A.Chief Executive Officer | Sale | 8,098 | $227.07K | Form 4 |
| May 6, 2026 | Foff Erin PennockChief Medical Officer | Sale | 15,900 | $463.17K | Form 4 |
| May 6, 2026 | Foff Erin PennockChief Medical Officer | Sale | 8,152 | $228.58K | Form 4 |
| May 6, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 16,421 | $478.34K | Form 4 |
| May 6, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 8,390 | $235.26K | Form 4 |
| May 6, 2026 | Setia VishwasChief Financial Officer | Sale | 2,068 | $60.12K | Form 4 |
| May 6, 2026 | Setia VishwasChief Financial Officer | Sale | 8,496 | $238.23K | Form 4 |
| May 5, 2026 | Lillie James WoodruffChief Scientific Officer | Sale | 10,132 | $284.91K | Form 4 |
| May 5, 2026 | Setia VishwasChief Financial Officer | Sale | 968 | $28.07K | Form 4 |
| May 5, 2026 | Setia VishwasChief Financial Officer | Sale | 9,935 | $279.37K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4